BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer.
about
A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinomaRisk based neoadjuvant chemotherapy in muscle invasive bladder cancermRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancerPlatinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder CancerExpression of BRCA1 and ERCC1 as predictive clinical outcome after radiochemotherapy in patients with locoregionally moderate-advanced nasopharyngeal carcinomaAssociation Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridinePrognostic significance of lymphovascular invasion in radical cystectomy on patients with bladder cancer: a systematic review and meta-analysis.Drug therapy for hereditary cancersIn Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein.Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapyBiomarkers for prognosis and treatment selection in advanced bladder cancer patients.Progress in personalizing chemotherapy for bladder cancerPersonalized therapy for urothelial cancer: review of the clinical evidence.Co-expression of ERCC1 and Snail is a prognostic but not predictive factor of cisplatin-based neoadjuvant chemotherapy for bladder cancerPersonalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer.Role of ABCG2 expression driven by cisplatin in platinum-containing chemotherapy for gastric cancerThe predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy.BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling.Pharmacogenomics in bladder cancer.Snail expression and outcome in T1 high-grade and T2 bladder cancer: a retrospective immunohistochemical analysisUrothelial cancers: using biology to improve outcomes.Novel molecular targets for the therapy of urothelial carcinoma.Emerging drugs for urothelial carcinoma.Selective organ preservation for the treatment of muscle-invasive transitional cell carcinoma of the bladder: a review of current and future perspectives.Noninvasive approaches for detecting and monitoring bladder cancer.Inhibitory member of the apoptosis-stimulating protein of p53 is overexpressed in bladder cancer and correlated to its progression.Update in Urothelial Carcinoma: Novel Agents and Targeted Therapy.Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial CarcinomaThe RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host.Prognostic and Predictive Value of O6-methylguanine Methyltransferase for Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.DNA repair pathways to regulate response to chemoradiotherapy in patients with locally advanced head and neck cancer.The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study.
P2860
Q21558626-92B59803-FE8D-49BE-879D-9460D3175EF4Q26773664-8D92108A-9072-4459-BFEA-D65D3E1F7938Q28246258-724B33ED-9A24-4012-A7EE-7ACBD0047275Q28552143-613BE699-3233-4B79-BE6F-0CCA8C39F6C5Q33761748-EE6FBDD9-5F43-4831-BFFB-2EEA86E2AE9EQ33911932-88E32ADC-85A2-49E3-BC39-074819120D05Q35089211-12A37574-A788-4D02-90BE-768C0CF2DB3DQ35106939-F012AD52-9D37-4DD2-B03F-7DB2C91401C8Q35208929-FA6CF5BA-8D77-46B9-AF47-45AF35AD508EQ35440379-59E875B7-D4C7-4F7B-AEB1-460A4CEEA695Q35667815-9103C261-7C1E-44A2-87C1-20E6E5938B49Q35671292-874A3912-0F8C-4D64-86D3-4F825642A5AAQ35779460-5FFCC260-9114-415E-A890-D9BF9B1DDFACQ36062762-2F20EE6A-938A-481C-9BBD-6CE0D56F84D3Q36099310-4B9251EE-D34E-45DC-A56C-702402BD7DCDQ36817080-3D9A551C-39CA-4A8C-820C-A941431ED496Q37021261-05A75E21-08AC-4CC9-AF12-B0EB711700C8Q37241606-E2F767CA-9B13-4DF8-83B5-22E70E3AFC0DQ37381571-2AE5E051-9503-45CB-A361-11476B9099C4Q37396876-BD2D6914-BB3E-4037-AD29-594EC866E34BQ37523551-1920A487-9585-4412-A5D3-92D91A133EE1Q37557751-4038D967-46DD-4458-B6C9-4A7AEA462DBEQ37965638-DFF9D095-2B51-40D6-816B-BCD400767173Q38003195-24CA8B08-8A50-4309-8A35-8B703230E5AFQ38160271-8384E2E6-FDCB-4B06-BA9F-C33909A018BBQ38255032-E3CC82E6-2733-4F24-959B-A36710476F1DQ38286089-24B694B4-D5C6-4006-8991-2BFAB0C5E05BQ38794118-0A212D38-B6B6-4D34-ADCA-58D8975B3E1DQ39766258-779BFD59-9483-446E-AB75-F71C9FA6E753Q40541109-1F1C3557-55F9-4941-9E0C-88FB1199846EQ41002840-80DE6071-01BF-46D9-8210-ECE79D25F540Q42874055-71AEAFDE-CD5B-4E42-8376-2204AD2AD0C2Q43879300-9717F6E5-73DD-48BF-AED3-3AE9C5F96657Q47223305-FD7686C0-D896-48FF-9DD7-DBEF3A4A8C10Q51611938-3227A2BE-6710-4781-A739-B2469E36C276Q54964281-7B73E198-7D6C-45C0-86C1-945934A246BF
P2860
BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
BRCA1 mRNA expression and outc ...... hemotherapy in bladder cancer.
@en
BRCA1 mRNA expression and outc ...... hemotherapy in bladder cancer.
@nl
type
label
BRCA1 mRNA expression and outc ...... hemotherapy in bladder cancer.
@en
BRCA1 mRNA expression and outc ...... hemotherapy in bladder cancer.
@nl
prefLabel
BRCA1 mRNA expression and outc ...... hemotherapy in bladder cancer.
@en
BRCA1 mRNA expression and outc ...... hemotherapy in bladder cancer.
@nl
P2093
P356
P1433
P1476
BRCA1 mRNA expression and outc ...... hemotherapy in bladder cancer.
@en
P2093
A Gimenez-Capitan
D Rodríguez
J J Sánchez
P304
P356
10.1093/ANNONC/MDQ333
P577
2010-07-05T00:00:00Z